Shares of Samsung BioLogics plunged on Wednesday after South Korea's financial regulators made a tentative decision that the biopharmaceutical company violated accounting rules. The Financial Supervisory Service said on Tuesday it notified the company and its accounting firms of its preliminary
See Original Article

The Financial Supervisory Service (FSS) has provisionally determined that fraudulent accounting occurred in Samsung BioLogics. Although the final result of its one-year investigation is yet to come, a severe punishment seems to be inevitable. The FSS has delivered the tentative outcome of its
See Original Article

By Joyce Lee. SEOUL, May 2 (Reuters) – Shares in Samsung BioLogics Co Ltd tumbled nearly 20 percent on Wednesday, losing almost $6 billion in value in their biggest daily intra-day fall, after South Korea's financial watchdog provisionally decided it had breached an accounting rule. The Financial
See Original Article

U.S. stocks edged lower Monday, as falling shares of health-care companies and industrial stocks nearly dashed major indexes' first month of gains since January.
See Original Article

The filing/administration gap; tinkering with reform; OIC's many plusses; and other highlights from our favorite tax bloggers. White Paper Metrics that Matter. It's impossible to predict with absolute certainty how the market will respond to a new technology, and it's just as difficult to predict when and where
See Original Article